Drug-Eluting Stent Implantation

Stent thrombosis after drug eluting stent implantation.

ince stent thrombosis (ST) is one of the serious and mortal complications after percutaneous coronary intervention (PCI), especially drug-eluting stent (DES) implantation, we are eager that the means of predicting and preventing ST be established. Several studies have reported an association between inflammation and stent thrombogenicity. In a clinical setting, Hwang et al1 reported a positive ...

drug-eluting stent fracture within 6 days after stent implantation

Endothelial dysfunction after drug eluting stent implantation.

Endothelial dysfunction has been implicated in the pathological process of coronary artery disease as well as an adverse event after coronary drug eluting stent (DES) implantation. In this review, an overview will be given of the evidence to date regarding the effects of coronary DES on endothelial function obtained from both clinical and experimental studies. Stenting in general and DES seem t...

Coronary aneurysm after drug-eluting stent implantation.

The use of drug-eluting stents aiming at by-pass the disadvantage of stainless steel stents have been associated to late thrombosis after withdrawal of anti-platelet agents. We report a case with another complication, the development of a coronary aneurysm in the stent area more than three years after index procedure. Late chronic local inflammatory responses may be responsible for the weakenin...

Very late stent thrombosis after implantation of drug eluting stent.

A case of late stent occlusion of a Sirolimus eluting Cypher stent (Cordis, Johnson and Johnson) presenting as acute ST elevation myocardial infarction 22 months after deployment is reported. The possible mechanisms are discussed.